
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 13.150 | 13.150 | 0.000 |
Shares | 88.270 | 88.660 | 0.390 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.839 | 19.266 |
Price to Book | 3.134 | 3.030 |
Price to Sales | 3.895 | 2.636 |
Price to Cash Flow | 11.313 | 11.426 |
Dividend Yield | 0.891 | 2.154 |
5 Years Earnings Growth | 14.953 | 12.590 |
Number of long holdings: 266
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 7.50 | 110.28 | 0.00% | |
Amgen | US0311621009 | 6.93 | 284.70 | +0.01% | |
Regeneron Pharma | US75886F1075 | 6.69 | 559.80 | +0.84% | |
Vertex | US92532F1003 | 6.47 | 375.63 | -2.60% | |
AstraZeneca ADR | US0463531089 | 3.31 | 74.57 | +1.32% | |
ProShares Ultra Nasdaq Biotechnology | US74347R2141 | 2.66 | 50.08 | -0.30% | |
Alnylam | US02043Q1076 | 2.64 | 435.10 | +1.63% | |
Biogen | US09062X1037 | 1.94 | 127.75 | -1.23% | |
Illumina | US4523271090 | 1.84 | 95.50 | +1.13% | |
argenx ADR | US04016X1019 | 1.72 | 672.35 | -0.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF NASDAQ 100 Index Fund QDII USD | 2.17B | 9.18 | 19.56 | 16.42 | ||
GF Global Selction Eq QDII USD | 1.36B | 9.92 | 20.77 | 12.00 | ||
GF American Estate Index QDII USD | 21.47M | -2.11 | 0.03 | 3.51 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review